Robust Analytical Tools for Life Science Applications

Fast, high-performance, easy-to-use, fully-integrated analytical solutions.

Revolutionizing the proteomics and protein-drugs analytical workflows.

Our technologies offer several unique capabilities that increase productivity in protein characterization.

Biotechnology-Salaries

About Us

GMJ Technologies, Inc. is an emerging leader in novel analytical technologies for efficient analytical workflows in biotherapeutic developments and the omics (proteomics and metabolomics). We are developing robust technologies that enhance productivity for researchers in all stages of biopharmaceutical developments and proteomics.

Read More

Our Technologies

Our proprietary OptoESITM interface permits coupling sensitive optical-MS detection with CE separation. It enables efficient coupling of UV absorbance or laser-induced fluorescence (LIF) with MS analysis.
OptoESITM Interface
OptoESI<sup>TM</sup> Interface
Our CeMAX UVTM employs next generation capillary electrophoresis with our proprietary optical-mass spectrometry interface (OptoESITM) to enable powerful applications in biopharmaceutical and biomedical protein characterization. Performs unlimited charge-based analyses with high reliability and ease of use.
CeMAX UVTM
CeMAX UV<sup>TM</sup>
Previous
Next
View All

Applications

Biologics

Notch up your biologics characterization with our CeMAX UVTM Achieve comprehensive characterization with integrated optical-MS data, profound efficiency, and robustness. Achieve analysis in 10 mins or less.

Read More

Omics

Achieve exquisite sensitivity with enhanced efficiency in proteomics and metabolomics with our CeMAX UVTM. Outstanding separation throughput debottlenecks your omics’ workflow and saves your precious time.

Read More

Particles

We offer unique utra-sensitive optical detection capabilities tailored to specific applications in VLP, Vaccines, and Gene Therapy developments. Minimize precious sample waste with our nanovial for 1 μL sample volume.

Read More
View More

News

image013

GMJ Awarded competitive $1M Phase II SBIR grant from the National Science Foundation (NSF)

GMJ Awarded Phase I SBIR grant from the National Science Foundation (NSF)

Read More
Read More
View All

Our Partners